|
시장보고서
상품코드
1671842
임상시험수탁기관 시장 : 서비스 유형별, 임상 모니터링, 치료 분야별, 최종사용자별, 지역별Contract Clinical Research Organization Market, By Service Type, Clinical Monitoring, By Therapeutic Area, By End User, By Geography |
||||||
세계 임상시험수탁기관 시장은 2025년에 877억 1,000만 달러로 추정되며, 2025년부터 2032년까지 CAGR 9.5%로 성장하여 2032년에는 1,655억 6,000만 달러에 달할 것으로 예상됩니다.
| 보고 대상 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 877억 1,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR | 9.50% | 2032년 가치 예측 | 1,655억 6,000만 달러 |
세계 임상시험수탁기관(CRO) 시장은 지난 몇 년간 꾸준한 성장세를 보이고 있으며, CRO는 제약, 생명공학, 의료기기 산업을 연구 서비스 아웃소싱의 형태로 지원하는 기업입니다. 임상시험 설계, 데이터 관리, 생물통계 분석, 약사 서비스 등을 제공합니다. 신약개발 프로세스의 진화는 제약기업에게 연구의 복잡성과 비용을 증가시켜 연구 활동의 아웃소싱을 강요하고 있습니다. 또한, 의약품 개발 주기가 단축됨에 따라 다양한 치료 분야에 대한 전문 지식과 인프라를 갖춘 외부 서비스 제공업체에 대한 수요가 증가하고 있습니다. 이러한 요인들은 임상시험수탁기관 시장의 성장을 크게 촉진하고 있습니다.
시장 역학:
제약기업의 연구개발(R&D) 지출 증가와 아웃소싱을 전략적으로 채택하는 사례가 증가함에 따라 세계 임상시험수탁기관 시장이 크게 성장하고 있습니다. 또한, 전문 임상시험 서비스에 대한 수요 증가와 첨단 기술의 급속한 발전은 이 시장에 새로운 기회를 창출하고 있습니다. 그러나 엄격한 규제와 승인까지의 시간 지연은 큰 도전이 되고 있습니다. 또한, 지적재산권(IP) 및 데이터 보안 관련 리스크도 시장 성장을 어느 정도 억제하고 있습니다. 제약사들은 현재 경쟁 우위를 확보하기 위해 품질, 전문성, 첨단 기술을 기반으로 한 CRO의 혁신적인 제공 모델을 채택하고 있습니다. 이는 향후 몇 년 동안 새로운 길을 열 것으로 예상됩니다.
본 조사의 주요 특징
세계의 임상시험수탁기관 시장을 상세히 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 정리하여 전해드립니다.
또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
본 보고서에서는 세계 임상시험수탁기관(CRO) 시장의 주요 기업 프로파일을 회사 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등의 항목을 기준으로 정리하여 수록하였습니다.
주요 조사 대상 기업은 IQVIA, Covance, Syneos Health, PPD(Pharmaceutical Product Development), ICON plc, Charles River Laboratories, Medpace, Parexel International, WuXi AppTec, PRA Health Sciences, KCR, Celerion, Catalent, BioClinica, Clinipace 등이 있습니다.
이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 임상시험수탁기관 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 드라이버
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER의 분석
- 인수합병 시나리오
- 업계 동향
제4장 세계의 임상시험수탁기관 시장, 서비스 유형별, 2020-2032년
- 임상시험 서비스
- 임상 모니터링
- 초기 개발 서비스
- 실험실 서비스
- 규제 관련 업무 서비스
제5장 세계의 임상시험수탁기관 시장, 치료 분야별, 2020-2032년
- 종양학
- 심혈관질환
- 감염증
- 신경학
- 기타 치료 분야
제6장 세계의 임상시험수탁기관 시장, 최종사용자별, 2020-2032년
- 제약회사
- 바이오테크놀러지 기업
- 의료기기 기업
- 조사·학술기관
제7장 세계의 임상시험수탁기관 시장, 지역별, 2020-2032년
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제8장 경쟁 구도
- IQVIA
- Covance
- Syneos Health
- PPD(Pharmaceutical Product Development)
- ICON plc
- Charles River Laboratories
- Medpace
- Parexel International
- WuXi AppTec
- PRA Health Sciences
- KCR
- Celerion
- Catalent
- BioClinica
- Clinipace
제9장 애널리스트의 추천사항
- Wheel of Fortune
- 애널리스트의 견해
- Coherent Opportunity Map
제10장 참고문헌과 조사 방법
- 참고문헌
- 조사 방법
- 출판사 소개
Global Contract Clinical Research Organization Market is estimated to be valued at US$ 87.71 Bn in 2025 and is expected to reach US$ 165.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | US$ 87.71 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.50% | 2032 Value Projection: | US$ 165.56 Bn |
The global contract clinical research organization market has been witnessing steady growth over the past few years. CROs are companies that support the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. They provide clinical trial design, data management, biostatistical analysis, regulatory affairs services, and other services. The evolution of drug discovery and development processes has increased research complexities and costs for pharmaceutical companies, compelling them to outsource their research activities. Moreover, abbreviated drug development cycles have increased the demand for external service providers having expertise and infrastructure across varied therapeutic areas. These factors have boosted the contract clinical research organization market growth significantly.
Market Dynamics:
Rising research and development (R&D) expenditure of pharmaceutical companies along with higher adoption of outsourcing as a strategy is significantly driving the global contract clinical research organization market. Moreover, increasing demand for specialized clinical trial services and rapid evolution of advanced technologies are creating new opportunities in this market. However, stringent regulations and slower approval timelines pose major challenges. Additionally, the intellectual property (IP) rights and data security related risks restrain market growth to some extent. Pharmaceutical companies are now adopting innovative delivery models from CROs driven by quality, expertise, and advanced technologies to gain competitive advantage. This is expected to open up new avenues over the coming years.
Key Features of the Study:
This report provides in-depth analysis of the global contract clinical research organization market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global contract clinical research organization (CRO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IQVIA, Covance, Syneos Health, PPD (Pharmaceutical Product Development), ICON plc, Charles River Laboratories, Medpace, Parexel International, WuXi AppTec, PRA Health Sciences, KCR, Celerion, Catalent, BioClinica, and Clinipace
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global contract clinical research organization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract clinical research organization market
Market Segmentation
- Service Type Insights (Revenue, USD Bn, 2020 - 2032)
- Clinical Trial Service
- Phase III
- Phase II
- Phase I
- Phase IV
- Clinical Monitoring
- Site Monitoring
- Data Monitoring
- Early phase development Services
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
- Laboratory Services
- Analytical Testing Services
- Bioanalytical Testing Services
- Regulatory Affairs Services
- Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Other Therapeutic Areas
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Research & Academic Institutions
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- IQVIA
- Covance
- Syneos Health
- PPD (Pharmaceutical Product Development)
- ICON plc
- Charles River Laboratories
- Medpace
- Parexel International
- WuXi AppTec
- PRA Health Sciences
- KCR
- Celerion
- Catalent
- BioClinica
- Clinipace
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Contract Clinical Research Organization Market, By Service Type
- Global Contract Clinical Research Organization Market, By Therapeutic Area
- Global Contract Clinical Research Organization Market, By End User
- Global Contract Clinical Research Organization Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Contract Clinical Research Organization Market, By Service Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Clinical Trial Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Phase III
- Phase II
- Phase I
- Phase IV
- Clinical Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Site Monitoring
- Data Monitoring
- Early phase development Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
- Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Analytical Testing Services
- Bioanalytical Testing Services
- Regulatory Affairs Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Contract Clinical Research Organization Market, By Therapeutic Area, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Therapeutic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Contract Clinical Research Organization Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research & Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Contract Clinical Research Organization Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- IQVIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Covance
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PPD (Pharmaceutical Product Development)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PRA Health Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Celerion
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Catalent
- BioClinica
- Clinipace
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About Us
